1. What platform will you be using to automate the Ovation™ system (e.g., Biomek FX, Tecan Freedom Evo, Caliper Sciclone, etc.)?
2. Which of the NuGEN products or solutions are you interested in automating?
3. Do you currently have automation expertise in house (i.e. automation engineer or programmer) who is familiar with your platform?
4. Are you interested in a completely turnkey automation solution or would you expect some minimal manual intervention?
5. What type of peripheral devices do you have installed or integrated with your liquid handling robot (e.g., plate stacker, hotels, Peltier units, thermocycler, plate reader, shaker)?
6. What do you anticipate your throughput needs to be (how many samples will you process per day, per week)?
7. Do you currently have other RNA amplification assays automated on your platform? If yes, which ones?
8. Are you currently using any of NuGEN’s products in a manual or semi-automated way?
9. Will your liquid handler need to remain available for other assays while Ovation reactions are in progress?
10. If NuGEN currently does not have an automation package for your platform, would you be interested in receiving consulting services to help develop one?
State/Region:*
Alabama
Alaska
Arizona
California
Colorado
Connecticut
Delaware
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Puerto Rico
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Washington
Washington, D.C.
West Virginia
Wisconsin
Wyoming
CANADA - Alberta
British Columbia
Labrador
Manitoba
New Brunswick
Newfoundland
Northwest Territories
Nova Scotia
Nunavut
Ontario
Prince Edward Island
Québec
Saskatchewan
Yukon
Other
Country:*
Argentina
Australia
Austria
Belgium
Brazil
Canada
Chile
China
Costa Rica
Czech Republic
Denmark
Dominican Republic
Egypt
Finland
France
Germany
Greece
Hungary
Iceland
India
Indonesia
Ireland
Israel
Italy
Japan
Jordan
Korea, South
Kuwait
Liechtenstein
Lithuania
Luxembourg
Mexico
Monaco
Morocco
Netherlands
New Zealand
Norway
Oman
Peru
Philippines
Poland
Portugal
Russia
Saudi Arabia
Singapore
South Africa
Spain
Sweden
Switzerland
Taiwan
Thailand
Turkey
Ukraine
United Arab Emirates
United Kingdom
United States
Uruguay
Venezuela
Yugoslavia
Thank you very much for completing this Questionnaire.